Clinical Study
Real-Life Management of Patients with Retinal Vein Occlusion Using I-Macula Web Platform
Figure 2
Central macular thickness at baseline and 12 months in 37 eyes with macular edema secondary to retinal vein occlusion treated with DEX implant and/or ranibizumab.